Literature DB >> 16337149

ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin.

Mi Hee Park1, Sang Min Lee, Jae Woong Lee, Dong Ju Son, Dong Cheul Moon, Do Young Yoon, Jin Tae Hong.   

Abstract

Erythropoietin (EPO), a hematopoietic factor, is also required for normal brain development, and its receptor is localized in brain. Our previous study showed that EPO promotes differentiation of neuronal stem cells into astrocytes. Since astrocytes have influence on the neuronal function, we investigated whether EPO-activated astrocytes could stimulate differentiation of neuronal stem cells into neurons. EPO did not promote neuronal differentiation of neuronal stem cells isolated from 17 day embryos, however, neuronal differentiation was promoted when the neuronal stem cells were co-cultured with astrocyte isolated from post neonatal (Day 1) rat brain. Moreover, neuronal differentiation was further promoted when the neuronal stem cells were cultured with astrocyte culture medium treated by EPO (10U/ml) showing increase of morphological differentiation, and expression of neuronal differentiation marker proteins, neurofilament, and tyrosine hydroxylase. The promoting effect of EPO-treated astrocyte medium was also found in the differentiation of PC12 cells. EPO-promoted morphological differentiation of neuronal stem cells as well as astrocytes was dose dependently reduced by treatment with anti-EPO receptor antibodies in culture with astrocyte culture medium. To clarify whether EPO itself or via production of well-known neurotropic factor could promote neuronal cell differentiation, we determined the level of neurotropic factors in the EPO-treated astrocytes. Compared to untreated astrocytes, EPO-treated astrocytes increased about 2-fold in beta-NGF and 3-4-fold in BMP2, but did not increase BNDF and NT-3 levels. Since the previous study showed that extracellular signal-regulated kinase (ERK) is involved in activation of astrocytes by EPO, we determined whether generation of neurotrophic factor may also be involved with the ERK pathway. In the presence of ERK inhibitor, PD98059, the generation of beta-NGF was diminished in a dose dependent manner consistent with the inhibiting effect on neuronal differentiation. These data demonstrate that EPO promotes neuronal cell differentiation through increased release of beta-NGF and BMP2 from astrocytes, and this effect may be associated with ERK pathway signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337149     DOI: 10.1016/j.bbrc.2005.10.218

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Recombinant Human Erythropoietin: Novel Strategies for Neuroprotective/Neuro-regenerative Treatment of Multiple Sclerosis.

Authors:  Claudia Bartels; Kira Späte; Henning Krampe; Hannelore Ehrenreich
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

2.  Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors.

Authors:  M Kondyli; G Gatzounis; A Kyritsis; J Varakis; M Assimakopoulou
Journal:  J Neurooncol       Date:  2010-03-25       Impact factor: 4.130

3.  Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation.

Authors:  Yong Kyoung Lee; Im Seop Choi; Young Heui Kim; Ki Ho Kim; Sang Yun Nam; Young Won Yun; Moon Soon Lee; Ki Wan Oh; Jin Tae Hong
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

4.  Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance.

Authors:  Yiting Cao; Justin D Lathia; Christine E Eyler; Qiulian Wu; Zhizhong Li; Hui Wang; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Genes Cancer       Date:  2010-01-01

5.  Erythropoietin sustains cognitive function and brain volume after neonatal stroke.

Authors:  Fernando F Gonzalez; Regina Abel; C Robert Almli; Dezhi Mu; Michael Wendland; Donna M Ferriero
Journal:  Dev Neurosci       Date:  2009-08-11       Impact factor: 2.984

6.  Neurotrophic Activity of Cultured Cell Line U87 is Up-Regulated by Proline-Rich Polypeptide Complex and Its Constituent Nonapeptide.

Authors:  Agnieszka Zabłocka; Małgorzata Mitkiewicz; Józefa Macała; Maria Janusz
Journal:  Cell Mol Neurobiol       Date:  2015-04-05       Impact factor: 5.046

Review 7.  The Indispensable Roles of Microglia and Astrocytes during Brain Development.

Authors:  Kitty Reemst; Stephen C Noctor; Paul J Lucassen; Elly M Hol
Journal:  Front Hum Neurosci       Date:  2016-11-08       Impact factor: 3.169

Review 8.  Oxidative Stress in Hypoxic-Ischemic Encephalopathy: Molecular Mechanisms and Therapeutic Strategies.

Authors:  Mingyi Zhao; Ping Zhu; Masayuki Fujino; Jian Zhuang; Huiming Guo; IdrisAhmed Sheikh; Lingling Zhao; Xiao-Kang Li
Journal:  Int J Mol Sci       Date:  2016-12-10       Impact factor: 5.923

Review 9.  Mechanisms of Endogenous Neuroprotective Effects of Astrocytes in Brain Injury.

Authors:  Michelle A Bylicky; Gregory P Mueller; Regina M Day
Journal:  Oxid Med Cell Longev       Date:  2018-04-01       Impact factor: 6.543

Review 10.  Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy.

Authors:  Brandon J Dixon; Cesar Reis; Wing Mann Ho; Jiping Tang; John H Zhang
Journal:  Int J Mol Sci       Date:  2015-09-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.